Daniel F Frantz

Epidemiology · 2002–2005

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Daniel F Frantz trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Hotamisligil

Who trusts Daniel F Frantz overall

  1. Haiming Cao
  2. Liangyou Rui
  3. Herbert Tilg

Papers from Daniel F Frantz's perspective

Ordered by how strongly the researchers Daniel F Frantz trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Prevention of fat-induced insulin resistance by salicylate. (Journal of Clinical Investigation)
  2. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. (Journal of Clinical Investigation)
  3. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
  4. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. (Journal of Clinical Investigation)
  5. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. (Journal of Clinical Endocrinology and Metabolism)
  6. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (Diabetes)
  7. Inflammatory pathways and insulin action (International Journal of Obesity)
  8. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis (Hepatology)
  9. Obesity is associated with macrophage accumulation in adipose tissue. (Journal of Clinical Investigation)
  10. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. (Diabetes)

Their papers